Aspirin for Asymptomatic Carotid Artery Stenosis

  1. Warren S. Browner, MD, MPH
  1. Veterans Affairs Medical Center, San Francisco, CA 94211

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Dr. Cote and colleagues [1] recently reported that aspirin therapy had no effect on the incidence of vascular events or death in asymptomatic patients with carotid narrowing (hazard ratio, 0.90 [95% CI, 0.62 to 1.33]. They interpreted the results of this excellent study as allowing them “to rule out, with 95% confidence, the possibility that aspirin may reduce the risk for the composite outcomes by 40% or more.” However, 95% CIs do not imply that investigators can be 95% confident: They simply indicate the range of results that are consistent with the measured point estimate [2, 3]. Confidence in being correct, especially 95% confidence, will usually require supporting evidence from other studies.

    Warren S. Browner, MD, MPH

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    References

    1. 1.
    2. 2.
    3. 3.
    « Previous | Next Article »Table of Contents

    Navigate This Article